Post-marketing Surveillance of Long-term Administration o... | NCT01129596 | Trialant

Post-marketing Surveillance of Long-term Administration o... | NCT01129596 | Trialant

Arms/Interventions Module

Interventions

Name	Type	Description	Arm Group Labels	Other Names
donepezil hydrochloride	Drug	This is a multicenter, open-labeled, practice-based, post-marketing surveillance study. Therefore, dosing is not specified.	1

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
The transition of clinical condition is evaluated comparing the result of HDS-R,MMSE with the time of study initiation		48 months(12 weeks and every 6 months)

Contacts/Locations Module

References Module

Citations

PubMed Identifier	Type	Citation	Retractions
29993162	Background	Arai H, Hashimoto N, Sumitomo K, Takase T, Ishii M. Disease state changes and safety of long-term donepezil hydrochloride administration in patients with Alzheimer's disease: Japan-Great Outcome of Long-term trial with Donepezil (J-GOLD). Psychogeriatrics. 2018 Sep;18(5):402-411. doi: 10.1111/psyg.12340. Epub 2018 Jul 11.

Ancestor Terms

ID	Term
D003704	Dementia
D001927	Brain Diseases
D002493	Central Nervous System Diseases
D009422	Nervous System Diseases
D024801	Tauopathies
D019636	Neurodegenerative Diseases
D019965	Neurocognitive Disorders
D001523	Mental Disorders

Ancestor Terms

ID	Term
D007189	Indans
D007192	Indenes
D011084	Polycyclic Aromatic Hydrocarbons
D006841	Hydrocarbons, Aromatic
D006844	Hydrocarbons, Cyclic
D006838	Hydrocarbons
D009930	Organic Chemicals
D010880	Piperidines
D006573	Heterocyclic Compounds, 1-Ring
D006571	Heterocyclic Compounds
D011083	Polycyclic Compounds